Ftse Mib
33.541,98
-0,49%
DAX
18.155,24
-0,04%
S&P 500
5.477,90
0,16%
NASDAQ
17.805,16
0,49%
Bitcoin
61.007,42
0,32%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ First Wave BioPharma Inc (FWBI) First Wave BioPharma Inc (FWBI) Notizie

FWBI

First Wave BioPharma (FWBI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:FWBI
DataOraFonteTitoloSimboloCompagnia
24/06/202414:03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FWBIFirst Wave BioPharma Inc
20/06/202422:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FWBIFirst Wave BioPharma Inc
17/06/202423:23Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:FWBIFirst Wave BioPharma Inc
14/06/202423:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FWBIFirst Wave BioPharma Inc
11/06/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FWBIFirst Wave BioPharma Inc
31/05/202423:25Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FWBIFirst Wave BioPharma Inc
30/05/202423:32Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:FWBIFirst Wave BioPharma Inc
30/05/202423:18Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FWBIFirst Wave BioPharma Inc
16/05/202413:00GlobeNewswire Inc.First Wave BioPharma Changes Name to Entero TherapeuticsNASDAQ:FWBIFirst Wave BioPharma Inc
14/05/202423:26Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FWBIFirst Wave BioPharma Inc
13/05/202422:59Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:FWBIFirst Wave BioPharma Inc
10/05/202413:55GlobeNewswire Inc.First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-MarketNASDAQ:FWBIFirst Wave BioPharma Inc
09/05/202413:00GlobeNewswire Inc.First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness MonthNASDAQ:FWBIFirst Wave BioPharma Inc
24/04/202413:00GlobeNewswire Inc.First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, NutrientsNASDAQ:FWBIFirst Wave BioPharma Inc
17/04/202413:00GlobeNewswire Inc.First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap ShowcaseNASDAQ:FWBIFirst Wave BioPharma Inc
15/04/202413:00GlobeNewswire Inc.First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders ConferenceNASDAQ:FWBIFirst Wave BioPharma Inc
18/03/202412:00GlobeNewswire Inc.First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) ConferenceNASDAQ:FWBIFirst Wave BioPharma Inc
14/03/202411:00GlobeNewswire Inc.First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical PipelineNASDAQ:FWBIFirst Wave BioPharma Inc
05/03/202413:00GlobeNewswire Inc.First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth ConferenceNASDAQ:FWBIFirst Wave BioPharma Inc
04/03/202414:00GlobeNewswire Inc.First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct OfferingNASDAQ:FWBIFirst Wave BioPharma Inc
13/02/202413:00GlobeNewswire Inc.First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024NASDAQ:FWBIFirst Wave BioPharma Inc
23/01/202413:00GlobeNewswire Inc.First Wave BioPharma to Present at the DealFlow MicroCap ConferenceNASDAQ:FWBIFirst Wave BioPharma Inc
17/01/202422:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FWBIFirst Wave BioPharma Inc
17/01/202413:00GlobeNewswire Inc.First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto RicoNASDAQ:FWBIFirst Wave BioPharma Inc
04/01/202412:00GlobeNewswire Inc.First Wave BioPharma Chairman and CEO Issues Letter to Shareholders Highlighting Recent Accomplishments and Outlook for 2024NASDAQ:FWBIFirst Wave BioPharma Inc
28/12/202318:21Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:FWBIFirst Wave BioPharma Inc
27/12/202317:55GlobeNewswire Inc.First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.8 Million Gross Proceeds PricedNASDAQ:FWBIFirst Wave BioPharma Inc
27/12/202314:04Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:FWBIFirst Wave BioPharma Inc
27/12/202312:00GlobeNewswire Inc.First Wave BioPharma Announces Streamlining of Clinical Pipeline with Non-Binding Term Sheet to Sell Niclosamide IBD ProgramNASDAQ:FWBIFirst Wave BioPharma Inc
18/12/202312:00GlobeNewswire Inc.First Wave BioPharma Announces Entry into Term Sheet for Business Combination with ImmunogenX Establishing a Leading Late-Stage GI-Focused Biopharmaceutical CompanyNASDAQ:FWBIFirst Wave BioPharma Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:FWBI

La tua Cronologia

NYSE
ABVT
EU
B358
Belgium Domestin bond Ol...
KUCN
NDAUUSDT
Ndau
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network